Burundi vs Cote d'Ivoire: Average non-HDL cholesterol levels
Burundi
2.8
in 2018
Cote d'Ivoire
2.8
in 2018
Burundi rank
163rd
Cote d'Ivoire rank
163rd
Average non-HDL cholesterol levels over time
- Burundi
- Cote d'Ivoire
How they compare
Burundi currently reports 2.8 against 2.8 in Cote d'Ivoire, a difference of 0.
Across all 39 years both countries report, Cote d'Ivoire has been ahead every year.
Burundi ranks 163rd and Cote d'Ivoire ranks 163rd of 191 countries.
Cote d'Ivoire has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Burundi | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.25 | 2.6 | 0.35 | Cote d'Ivoire |
| 1990s | 2.4 | 2.7 | 0.3 | Cote d'Ivoire |
| 2000s | 2.57 | 2.72 | 0.15 | Cote d'Ivoire |
| 2010s | 2.76 | 2.8 | 0.0444 | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Burundi or Cote d'Ivoire?
- Burundi, at 2.8 against 2.8 in Cote d'Ivoire as of 2018.
- What is the difference in average non-hdl cholesterol levels between Burundi and Cote d'Ivoire?
- 0, with Burundi ahead.
- How many years of comparable data are there for Burundi and Cote d'Ivoire?
- 39 years are reported by both, from 1980 to 2018.
- How do Burundi and Cote d'Ivoire rank globally for average non-hdl cholesterol levels?
- Burundi ranks 163rd and Cote d'Ivoire ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.